
|Articles|February 1, 1996
The American Journal of Managed Care
- February 1996
- Volume 2
- Issue 2
Pharmacoeconomic Impact of Injectable Sumatriptan on Migraine-Associated Healthcare Costs
Advertisement
Articles in this issue
over 29 years ago
Adapting Pharmacy Services to the Needs of Managed Careover 29 years ago
Advanced Practice Nurses and Success of Organized Delivery Systemsover 29 years ago
Ethical Issues in Managed Careover 29 years ago
The Economics of Compliance in Managed Healthcare SettingsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
4
Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits
5















































